Jan 22, 2026 | Drug & Alcohol Testing News
According to the results of a new study recently published in the journal Alcohol and Alcoholism, avoiding alcohol consumption for just one month can lead to significant physical and psychological benefits, such as improved sleep, better mood, and weight loss....
Jan 19, 2026 | Drug & Alcohol Testing News
A recent Jacobin interview conducted by Chandler Dandridge explored psychological and social frameworks for understanding addiction through a discussion with Hanna Pickard, Bloomberg Distinguished Professor of Philosophy and Bioethics and Krieger-Eisenhower Professor...
Jan 15, 2026 | Drug & Alcohol Testing News
According to the results of a new scientific study, strong clinical evidence supports only a limited number of medical uses for cannabis, revealing a gap between popular beliefs and current scientific evidence. The research study, which was recently published in the...
Jan 13, 2026 | Drug & Alcohol Testing News
A new vaccine designed to block the effects of fentanyl will enter human clinical trials early in 2026 to evaluate its safety. The vaccine, originally developed using funding from the U.S. Department of Defense, has already demonstrated promising results in rat...
Jan 9, 2026 | Drug & Alcohol Testing News
A recent review article published in Psychology Today and authored by Dr. Mark Gold examined evidence showing that substance use disorders (SUD) and withdrawal from addictive substances are associated with increased pain sensitivity, with implications for pain...
Jan 7, 2026 | Drug & Alcohol Testing News
Earlier in December, a drug alert was issued in Thunder Bay due to the detection of cychlorphine, a synthetic opioid that is unauthorized to be sold on the market. The warning was issued by NorWest Community Health Centres (NWCHC), stating that cychlorphine was...
